E. Isenhart

Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers

K. Eng, G. Chatta, M. Moffitt, 2022, Cancers.

MAGEC3 is a prognostic biomarker in ovarian and kidney cancers

K. Eng, G. Chatta, M. Moffitt, 2021, medRxiv.

Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers

K. Eng, J. Ohm, S. Rosario, 2022, medRxiv.

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers

Song Liu, M. Churchman, S. Rosario, 2023, International journal of molecular sciences.

Having less and wanting more: an investigation of socioeconomic status and reinforcement pathology

J. Temple, K. Balantekin, A. Ziegler, 2021, BMC Public Health.

Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer

S. Ramakrishnan, Anna Woloszynska, Jianmin Wang, 2024, Genome medicine.